{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:56:39Z","timestamp":1791356199035,"version":"4.3.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1006\/mgme.2001.3187","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T15:46:30Z","timestamp":1032363990000},"page":"179-187","source":"Crossref","is-referenced-by-count":15,"title":["A Novel Neurodevelopmental Syndrome Responsive to 5-Hydroxytryptophan and Carbidopa"],"prefix":"10.1006","volume":"73","author":[{"given":"V.Th.","family":"Ramaekers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Senderek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"H\u00e4usler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"H\u00e4ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Abeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Zerres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Heimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Blau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/mgme.2001.3187_RF1","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0031-9384(95)00156-D","article-title":"Behavioral and neurochemical changes in folate-deficient mice","volume":"58","author":"Gospe","year":"1995","journal-title":"Physiol Behav"},{"key":"10.1006\/mgme.2001.3187_RF2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1152\/physrev.1992.72.1.165","article-title":"Structure and function of the brain serotonin system","volume":"72","author":"Jacobs","year":"1992","journal-title":"Physiol Rev"},{"key":"10.1006\/mgme.2001.3187_RF3","series-title":"The Metabolic and Molecular Bases of Inherited Disease, 8th ed","first-page":"1275","article-title":"Disorders of tetrahydrobiopterin and related biogenic amines","author":"Blau","year":"2000"},{"key":"10.1006\/mgme.2001.3187_RF4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1023\/A:1005587719505","article-title":"Neurochemistry and defects of biogenic amine neurotransmitter metabolism","volume":"22","author":"Hyland","year":"1999","journal-title":"J Inherit Metab Dis"},{"key":"10.1006\/mgme.2001.3187_RF5","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0888-7543(05)80383-0","article-title":"Chromosomal localization of the human vesicular amine transporter genes","volume":"18","author":"Peter","year":"1993","journal-title":"Genomics"},{"key":"10.1006\/mgme.2001.3187_RF6","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1523\/JNEUROSCI.15-09-06179.1995","article-title":"Differential, expression of two vesicular monoamine transporters","volume":"15","author":"Peter","year":"1995","journal-title":"J Neurosci"},{"key":"10.1006\/mgme.2001.3187_RF7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF01276434","article-title":"Organisation of the human serotonin transporter gene","volume":"95","author":"Lesch","year":"1994","journal-title":"J Neural Trans"},{"key":"10.1006\/mgme.2001.3187_RF8","series-title":"Principles of Neural Science","first-page":"869","article-title":"Disorders of mood: Depression, mania, and anxiety disorders","author":"Kandel","year":"1991"},{"key":"10.1006\/mgme.2001.3187_RF9","series-title":"Principles of Neural Science","first-page":"683","article-title":"The brain stem: Cranial nerve nuclei and the monoaminergic systems","author":"Role","year":"1991"},{"key":"10.1006\/mgme.2001.3187_RF10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/1531-8249(199903)45:3<287::AID-ANA3>3.0.CO;2-9","article-title":"Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children","volume":"45","author":"Chugani","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1006\/mgme.2001.3187_RF11","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0140-6736(96)90079-3","article-title":"Polymorphism in serotonin transporter gene associated with susceptibility to major depression","volume":"347","author":"Ogilvie","year":"1996","journal-title":"Lancet"},{"key":"10.1006\/mgme.2001.3187_RF12","first-page":"271","article-title":"Low brain serotonin turnover rate (low CSF 5-HIAA) and impulsive violence","volume":"20","author":"Virkkunen","year":"1995","journal-title":"J Psychiatry Neurosci"},{"key":"10.1006\/mgme.2001.3187_RF13","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJM196711232772101","article-title":"Inhibition of serotonin synthesis by para-chlorophenylalanine in patients with the carcinoid syndrome","volume":"277","author":"Engelman","year":"1967","journal-title":"N Eng J Med"},{"key":"10.1006\/mgme.2001.3187_RF14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1113\/jphysiol.1954.sp005040","article-title":"Injections of drugs into lateral ventricles of the cat","volume":"123","author":"Feldberg","year":"1954","journal-title":"J Physiol (London)"},{"key":"10.1006\/mgme.2001.3187_RF15","first-page":"A8","article-title":"Neurotransmitter abnormalities in Hartnup disease","volume":"41","author":"Jonas","year":"1987","journal-title":"Am J Hum Genet"},{"key":"10.1006\/mgme.2001.3187_RF16","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/BF00711908","article-title":"Biochemical pathogenesis of subacute combined degeneration of the spinal cord and brain","volume":"16","author":"Surtees","year":"1993","journal-title":"J Inherit Metab Dis"},{"key":"10.1006\/mgme.2001.3187_RF17","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/BF00711900","article-title":"Abnormalities of biogenic amine metabolism","volume":"16","author":"Hyland","year":"1993","journal-title":"J Inherit Metab Dis"},{"key":"10.1006\/mgme.2001.3187_RF18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1023\/A:1005584627797","article-title":"Variant of dihydropteridine reductase deficiency without hyperphenylalaninemia: Effect of oral phenylalanine loading","volume":"22","author":"Blau","year":"1999","journal-title":"J Inherit Metab Dis"},{"key":"10.1006\/mgme.2001.3187_RF19","series-title":"Techniques in Diagnostic Human Biochemical Genetics","first-page":"377","article-title":"Pterins","author":"Curtius","year":"1991"},{"key":"10.1006\/mgme.2001.3187_RF20","series-title":"Physician's Guide to the Laboratory Diagnosis of Metabolic Diseases, Chap 2, pp 79\u201398; Chap 13, pp 223\u2013246","author":"Blau","year":"1996"},{"key":"10.1006\/mgme.2001.3187_RF21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0009-9120(86)80009-1","article-title":"Determination of a reference range for whole blood serotonin in a pediatric population using high pressure liquid chromatography with electrochemical detection","volume":"19","author":"Goldsmith","year":"1986","journal-title":"Clin Biochem"},{"key":"10.1006\/mgme.2001.3187_RF22","first-page":"609","article-title":"Quantification of urinary catecholamines, their abundant metabolites, and 5-hydroxyindoleacetic acid by high performance liquid chromatography and electrochemical detection, using a single mobile phase and uniform isocratic conditions","volume":"32","author":"Radjaipour","year":"1994","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"10.1006\/mgme.2001.3187_RF23","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1093\/nar\/18.14.4257","article-title":"Complete coding sequence of human tryptophan hydroxylase","volume":"18","author":"Boularand","year":"1990","journal-title":"Nucleic Acids Res"},{"key":"10.1006\/mgme.2001.3187_RF24","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1074\/jbc.270.8.3748","article-title":"The human tryptophan hydroxylase gene","volume":"270","author":"Boularand","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1006\/mgme.2001.3187_RF25","series-title":"The Hyperphenylalaninemias. A Differential Diagnosis and International Database of Tetrahydrobiopterin Deficiencies","author":"Blau","year":"1996"},{"key":"10.1006\/mgme.2001.3187_RF26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/026988119701100416","article-title":"Rapid depletion of plasma tryptophan: A review of studies and experimental methodology","volume":"11","author":"Reilly","year":"1997","journal-title":"J Psychopharmacol"},{"key":"10.1006\/mgme.2001.3187_RF27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1254\/jjp.70.203","article-title":"Functional interaction between serotonin and other neuronal systems: Focus on in vivo microdialysis studies","volume":"70","author":"Saito","year":"1996","journal-title":"Jpn J Pharmacol"},{"key":"10.1006\/mgme.2001.3187_RF28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0006-8993(00)03004-3","article-title":"M100,907, a selective 5-HT (2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex","volume":"888","author":"Pehek","year":"2001","journal-title":"Brain Res"},{"key":"10.1006\/mgme.2001.3187_RF29","doi-asserted-by":"crossref","first-page":"12259","DOI":"10.1074\/jbc.273.20.12259","article-title":"Expression and characterization of the catalytic core of tryptophan hydroxylase","volume":"273","author":"Moran","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1006\/mgme.2001.3187_RF30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000133075","article-title":"Localization of human tryptophan hydroxylase (TPH) to chromosome 11p15.3\u2013p14 by in situ hybridization","volume":"56","author":"Craig","year":"1991","journal-title":"Cytogenet Cell Genet"},{"key":"10.1006\/mgme.2001.3187_RF31","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1046\/j.1471-4159.1997.68052220.x","article-title":"Phosphorylation and activation of brain tryptophan hydroxylase: Identification of serine-58 as a substrate site for protein kinase A","volume":"68","author":"Kuhn","year":"1997","journal-title":"J Neurochem"},{"key":"10.1006\/mgme.2001.3187_RF32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/sj.mp.4000647","article-title":"Identification and analysis of new sequence variants in the human tryptophan hydroxylase (TpH) gene","volume":"5","author":"Paoloni-Giacobino","year":"2000","journal-title":"Mol Psychiatry"},{"key":"10.1006\/mgme.2001.3187_RF33","doi-asserted-by":"crossref","first-page":"29726","DOI":"10.1074\/jbc.274.42.29726","article-title":"Peroxynitrite inactivates tryptophan hydroxylase via sulfhydryl oxidation","volume":"274","author":"Kuhn","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1006\/mgme.2001.3187_RF34","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1017\/S0033291700038447","article-title":"Folate deficiency, biopterin and monoamine metabolism in depression","volume":"22","author":"Bottiglieri","year":"1992","journal-title":"Psychol Med"},{"key":"10.1006\/mgme.2001.3187_RF35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1600-0773.1978.tb02229.x","article-title":"The effect of aromatic amino acid decarboxylase inhibitor on plasma concentrations of 5-hydroxytryptophan in man","volume":"43","author":"Magnussen","year":"1978","journal-title":"Acta Pharmacol Toxicol"},{"key":"10.1006\/mgme.2001.3187_RF36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1600-0773.1980.tb02451.x","article-title":"Bioavailability and related pharmacokinetics in man of orally administrated L-5-hydroxytryptophan in steady state","volume":"46","author":"Magnussen","year":"1980","journal-title":"Acta Pharmacol Toxicol"},{"key":"10.1006\/mgme.2001.3187_RF37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0166-2236(93)90162-F","article-title":"Neurotransmitters as growth regulatory signals: Role of receptors and second messengers","volume":"16","author":"Lauder","year":"1993","journal-title":"Trends Neurosci"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719201931877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719201931877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T18:53:42Z","timestamp":1576522422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719201931877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["S1096719201931877"],"URL":"https:\/\/doi.org\/10.1006\/mgme.2001.3187","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}